Search

69 results

Reset

AlertsAug 6, 2018

Urgent need for Burkholderia phages for 20-year-old CF patient with a B. gladiola infection

We are urgently seeking Burkholderia phages for a 20-year-old cystic fibrosis patient. Ways to help at this stage: - By providing samples of your phages for testing (you send your phages to another lab that receives the patient’s isolate)

Alerts Burkholderia Cystic Fibrosis Phage Therapy
AlertsJan 3, 2018

Need Mycobacterium & P. aeruginosa phages for CF patient

Hi all, We are seeking Non-Tuberculous Mycobacterium & Pseudomonas aeruginosa phages for an 18-year-old cystic fibrosis patient in Los Angeles, to be tested on her lung isolates. Email us at staff@phage.directory if: - you have any Mycoba

Alerts Mycobacterium Pseudomonas aeruginosa Cystic Fibrosis Phage Therapy
AlertsDec 20, 2017

Need Burkholderia cepacia phages for CF patient

Hi all, Thanks for joining Phage Directory. We need your help. We urgently need Burkholderia cepacia phages for a lung transplant patient in Marseille, France. Email us at staff@phage.directory if: - you have B. cepacia phages - you are n

Alerts Burkholderia cepacia Lung Transplant Phage Therapy Cystic Fibrosis
Therapy studies

Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis

Completed. Checked 2026-10-03. Phase 1b/2a, double-blind, randomized, placebo-controlled, single and multiple ascending dose study to evaluate the safety, tolerability and phage recovery profile of AP-PA02 multi-bacteriophage therapeutic ca

phage bacteriophage cystic fibrosis Pseudomonas Pseudomonas aeruginosa
Therapy studies

A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa

Completed. Checked 2026-10-03. This is a phase 1b/2 study of a single dose of intravenous (IV) bacteriophage in males and non-pregnant females, at least 18 years old, diagnosed with Cystic Fibrosis (CF). This clinical trial is designed to a

Bacteriophage therapy colonized Cystic Fibrosis double-blind Microbiological Activity placebo-controlled Pseudomonas aeruginosa randomized Safety
Therapy studies

Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria

Invitation only. Checked 2026-10-03. About 10 people with cystic fibrosis (CF) and persistent Nontuberculosis mycobacteria (NTM) infection despite treatment will be screened to find out if their NTM infection has at least one mycobacterioph

cystic fibrosis phage mycobacteriophage
Therapy studies

Establishing Personalized Phage Therapy and Its Comparative Cost in Difficult-to-treat Infections (EPHICACI)

Recruiting. Checked 2026-10-03. EPHICACI is a multicenter, prospective study that continues and expands the monocentric PHAGEFORCE registry initiated at UZ Leuven. In Belgium, phage therapy can be applied as standard-of-care only in patient

Bacteriophage therapy Personalized treatment Difficult-to-treat infection Antimicrobial resistance Musculoskeletal infections Chronic rhinosinusitis Persistent bacteremia Pulmonary infections Cystic fibrosis Bronchiectasis Hidradenitis suppurativa
Therapy studies

Bacteriophages for Adults With Cystic Fibrosis and Chronic Achromobacter Lung Infection

Recruiting. Checked 2026-10-03. The goal of this clinical trial is to learn if a new treatment called AchromoPhage is safe and well tolerated in adults with cystic fibrosis (CF) who have long-term lung infections caused by Achromobacter bac

Bacteriophage Therapy Phage Therapy AchromoPhage Multidrug-Resistant Infections Lung Infection Pulmonary Infection cystic fibrosis Achromobacter
Therapy studies

Safety of Combined Intravenous Antibiotic and Bacteriophage Therapy in Adults With Cystic Fibrosis and Antibiotic-Resistant Lung Infections

Not yet recruiting. Checked 2026-10-03. This is a Phase 1, open-label, multi-center pilot study evaluating the safety and microbiological activity of intravenous (IV) bacteriophage therapy in combination with standard IV antibiotics in adul

cystic fibrosis CF Phage bacteriophage